STUDY OF THE EFFECTIVENESS OF BIFIDUMBACTERIN FOR THE PROPHYLAXIS OF PURULENT INFLAMMATORY DISEASES

被引:0
|
作者
CHERNYATINA, LF
BEREZHNOI, VF
TULUPOVA, AA
机构
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:36 / 40
页数:5
相关论文
共 50 条
  • [32] PREVENTION OF ACUTE PURULENT DISEASES OF HAND
    SHABANOV, AN
    DMITRIEV, AE
    OSTROVSKII, VK
    [J]. SOVETSKAYA MEDITSINA, 1975, (11): : 82 - 85
  • [33] PATHOGENESIS AND TREATMENT OF PURULENT DISEASES OF THE LUNGS
    MUROMSKY, YA
    GUKASYAN, EA
    SEMIVOLKOV, VI
    SAVITSKAYA, KI
    EGORKINA, DA
    YUNOVIDOVA, LI
    BAKLYKOVA, SN
    BAIKOV, SN
    SOLODILOVA, OE
    [J]. KHIRURGIYA, 1988, (12): : 12 - 18
  • [34] ACTIVITY OF PHAGOCYTES IN PATIENTS WITH PURULENT DISEASES
    SESTAKOVA, H
    JOHN, C
    KALVODOVA, D
    [J]. FOLIA MICROBIOLOGICA, 1984, 29 (05) : 416 - 416
  • [36] PROTEOLYTIC-ENZYMES IN THERAPY OF PURULENT-INFLAMMATORY DISEASES OF SKIN AND SUBCUTANEOUS CONNECTIVE-TISSUE
    GLOZMAN, VN
    [J]. SOVETSKAYA MEDITSINA, 1975, (03): : 152 - 153
  • [37] Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
    Buisson, Anthony
    Nachury, Maria
    Reymond, Maud
    Yzet, Clara
    Wils, Pauline
    Payen, Laure
    Laugie, Marie
    Manlay, Luc
    Mathieu, Nicolas
    Pereira, Bruno
    Fumery, Mathurin
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2338 - 2346
  • [38] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    Singh, Siddharth
    Andersen, Nynne Nyboe
    Andersson, Mikael
    Loftus, Edward V., Jr.
    Jess, Tine
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
  • [39] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    Singh, Siddharth
    Andersen, Nynne Nyboe
    Andersson, Mikael
    Loftus, Edward V., Jr.
    Jess, Tine
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
  • [40] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    不详
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260